~~<i id='0589E71CAB'><strike id='0589E71CAB'><tt id='0589E71CAB'><pre id='0589E71CAB'></pre></tt></strike></i>~~

Home» knowledge» hotspot

hotspot

author：focus 2025-09-28 03:43:59 Page View：7

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： CRISPR pioneers react to Casgevy, first gene
Next article： In age of alternative facts, a scholarly course on calling out crap

explore

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Congress must reauthorize a committee to support older Americans

OlderadultsandfirstresponderswaitinlinetoreceiveaCovid-19vaccineattheLakesRegionalLibraryinDecember2

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Poor hospice wound care hurts patients and families

AdobeAfewyearsago,Iworkedwithapatientcloseto100yearsold.Shehaddiabetesformostofheradultlife,whichaff

WSS

hotspot

hotspot

leisure time

explore

Poor hospice wound care hurts patients and families